How AstraZeneca and Mass General Brigham are Enhancing Clinical Trial Protocol Design
The SCOPE 2025 Summit showcased a groundbreaking partnership between Mass General Brigham (MGB), AstraZeneca, and Evinova, highlighting how these...
The SCOPE 2025 Summit showcased a groundbreaking partnership between Mass General Brigham (MGB), AstraZeneca, and Evinova, highlighting how these...
The 2025 SCOPE Summit’s fireside chat focused on how companies are preparing and upskilling their clinical trial workforce to...
At the SCOPE Summit 2025 Conference, a panel discussion titled “Redesigning Site Contract and Clinical Trial Budget Negotiations to...
In this interview, we engage with Dalton Signor, CEO at Miist Therapeutics, to explore their innovative inhaled therapies for...
In this interview, we sat down with James Burt, CEO of Pharmanovia, to reflect on industry trends from 2024...
In this discussion with Kathleen Mandziuk, Vice President of eClinical Development & Delivery at ICON, we explore the dynamic...
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials....
In this interview, we conversed with Pete Govorchin, President, City of Hope® Cancer Center Chicago and Edward S. Kim,...
In this conversation with Dominique Demolle, CEO of Cognivia, we explore the power of understanding patient psychology to enhance...
In the dynamic world of clinical trials, Yunu is revolutionizing imaging services with cutting-edge technology and strategic partnerships. Jeffrey...